Singapore – October 18, 2026 -- HistoIndex and Singapore's Agency for Science, Technology and Research (A*STAR) have signed a Memorandum of Understanding to jointly run preclinical evaluation and characterization of therapeutic candidates for fibrotic diseases, including cancer-associated fibrosis.